Humana Inc: Form 10-Q for the period ended Mar 31, 2018
Filed with the SEC on May 2, 2018 and accepted by EDGAR at May 2, 2018, 13:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-01-01 to 2018-03-31 | $14.28bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2018-01-01 to 2018-03-31 | $1.75bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-01-01 to 2018-03-31 | $760.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-01-01 to 2018-03-31 | $53.0m | us-gaap:InterestExpense |
| Income tax | 3 months2018-01-01 to 2018-03-31 | $216.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-01-01 to 2018-03-31 | $491.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-01-01 to 2018-03-31 | $3.53 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-01-01 to 2018-03-31 | $3.56 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-01-01 to 2018-03-31 | 138,830,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2018-01-01 to 2018-03-31 | $3.69bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2018-01-01 to 2018-03-31 | $134.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2018-01-01 to 2018-03-31 | $57.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months2018-01-01 to 2018-03-31 | $51.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-03-31 | $8.86bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-03-31 | $23.93bn | us-gaap:AssetsCurrent |
| Total assets | At period end2018-03-31 | $33.45bn | us-gaap:Assets |
| Current liabilities | At period end2018-03-31 | $15.46bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-03-31 | $23.37bn | us-gaap:Liabilities |
| Long-term debt | At period end2018-03-31 | $4.77bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2018-03-31 | $398.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2018-03-31 | $10.08bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2018-03-31 | 137,682,171 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000049071-18-000062. Last ingested by Listed: Nov 10, 2026, 18:12 ET. Listed shows no prices and gives no investment advice.